115479-40-8

Basic information

• Product Name: 2-Amino-4-chloro-7-(2,3-O-isopropylidene-5-O-tert-butyldimethylsily--D-ribofuranosyl)pyrrolo[2,3,-d]pyrimidine
• Synonyms: 2-Amino-4-chloro-7-(2,3-O-isopropylidene-5-O-tert-butyldimethylsily--D-ribofuranosyl)pyrrolo[2,3,-d]pyrimidine;4-Chloro-7-[5-O-[(1,1-dimethylethyl)dimethylsilyl]-2,3-O-(1-methylethylidene)--D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-2-amine;9-(5'-O-t-Butyldimethylsilyl-2',3'-O-isopropylidene-b-D-ribofuranosyl)-6-chloro-7-deazaguanine
• CAS NO: 115479-40-8
• Molecular Formula: C₂₀H₃₁ClN₄O₄Si
• Molecular Weight: 455.02
• Product Categories: Carbohydrates & Derivatives;Chiral Reagents;Heterocycles;Carbohydrates & Derivatives, Chiral Reagents, Heterocycles
• Mol File: 115479-40-8.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• Refractive Index: 1.603
• Solubility: Chloroform, Dichloromethane, Ethyl Acetate
• CAS DataBase Reference: 2-Amino-4-chloro-7-(2,3-O-isopropylidene-5-O-tert-butyldimethylsily--D-ribofuranosyl)pyrrolo[2,3,-d]pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Amino-4-chloro-7-(2,3-O-isopropylidene-5-O-tert-butyldimethylsily--D-ribofuranosyl)pyrrolo[2,3,-d]pyrimidine(115479-40-8)
• EPA Substance Registry System: 2-Amino-4-chloro-7-(2,3-O-isopropylidene-5-O-tert-butyldimethylsily--D-ribofuranosyl)pyrrolo[2,3,-d]pyrimidine(115479-40-8)

Safety Data

• Hazardous Substances Data: 115479-40-8(Hazardous Substances Data)

Usage

Chemical Properties

Foamy Solid

Uses

4-Chloro-7-[5-O-[(1,1-dimethylethyl)dimethylsilyl]-2,3-O-(1-methylethylidene)_x000D_-β-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-2-amine (cas# 115479-40-8) is a compound useful in organic synthesis.

InChI:InChI=1/C20H31ClN4O4Si/c1-19(2,3)30(6,7)26-10-12-13-14(29-20(4,5)28-13)17(27-12)25-9-8-11-15(21)23-18(22)24-16(11)25/h8-9,12-14,17H,10H2,1-7H3,(H2,22,23,24)/t12-,13+,14+,17-/m1/s1

Upstream product

• 18162-48-6 tert-butyldimethylsilyl chloride 
• 67814-68-0 2,3-O-isopropylidene-D-ribofuranose 
• 532-20-7 D-Ribose 
• 217309-46-1 5-(tert-butyldimethylsilyloxy)-2,3-isopropylidenedioxy-D-ribofuranose 
• 84955-31-7 4-chloro-7H-pyrrolo[2,3-d]pyrimidin-2-amine 
• 102690-95-9 5-O-<(1,1-dimethylethyl)dimethylsilyl>-2,3-O-(1-methylethylidene)-β-D-ribofuranosyl chloride 
• 102690-94-8 2,3-O-isopropylidene-5-O-(tert-butyldimethylsilyl)-α-D-ribofuranosyl chloride 

Downstream Products

• 62160-23-0 2-amino-7-β-D-ribofuranosylpyrrolo<2,3-d>pyrimidin-4(3H)-one 
• 115479-42-0 2-Amino-4-methoxy-7-β-D-ribofuranosylpyrrolo<2,3-d>pyrimidine 
• 62160-23-0 7-deazaguanosine 
• 444019-16-3 2-[(4-monomethoxytrityl)amino]-7-(2-O-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4(3H)-one 
• 444019-20-9 2-[(p-anisyldiphenylmethyl)amino]-7-(3-deoxy-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4(3H)-one 
• 131981-22-1 7-{5'-O-[(1,1-dimethylethyl)dimethylsilyl]-2',3'-O-(1-methylethylidene)-β-D-ribofuranosyl}-4-methoxy-7H-pyrrolo[2,3-d]pyrimidin-2-amine 
• 120401-36-7 2-amino-4-chloro-7-(β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine 

Relevant articles and documents

Synthesis and Properties of 2′-OMe-RNAs Modified with Cross-Linkable 7-Deazaguanosine Derivatives

Cross-linkable 7-deaza-6-vinylguanosine (ADVP) and 7-propynyl-7-deaza-6-vinylguanosine (ADpVP) derivatives were synthesized and successfully incorporated into 2′-OMe-RNA oligonucleotides by solid-phase oligonucleotide synthesis. Analysis of their cross-li

S-ANTIGEN TRANSPORT INHIBITING OLIGONUCLEOTIDE POLYMERS AND METHODS

Various embodiments provide STOPS? polymers that are S-antigen transport inhibiting oligonucleotide polymers, processes for making them and methods of using them to treat diseases and conditions. In some embodiments the STOPS? modified oligonucleotides include an at least partially phosphorothioated sequence of alternating A and C units having modifications as described herein. The sequence independent antiviral activity against hepatitis B of embodiments of STOPS? modified oligonucleotides, as determined by HBsAg Secretion Assay, is an EC50 that is less than 100 nM.

CYCLIC DI-NUCLEOTIDE COMPOUNDS AND METHODS OF USE

Disclosed are cyclic-di-nucleotide cGAMP analogs, methods of synthesizing the compounds, pharmaceutical compositions comprising the compounds thereof, and use of compounds and compositions in medical therapy.